Health Sciences Acquisitions Corporation Warrants
HSACW
HSACW was delisted on the 18th of December, 2019.
0 hedge funds and large institutions have $0 invested in Health Sciences Acquisitions Corporation Warrants in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 11 closing their positions.
100% less funds holding
Funds holding: 11 → 0 (-11)
100% less capital invested
Capital invested by funds: $6.61M → $0 (-$6.61M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 11
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$4.33M |
| 2 |
GL
Governors Lane
New York
|
-$696K |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
-$399K |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$233K |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$84K |
HSACW Hedge Fund Activity: Q4 2019 in Review
0 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Health Sciences Acquisitions Corporation Warrants (HSACW) for Q4 2019, worth a combined $0 — down 100% from $6.61M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of HSACW and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Boothbay Fund Management, exiting entirely with an estimated $4.33M sold.
- 0 institutional investors held Health Sciences Acquisitions Corporation Warrants (HSACW) as of Q4 2019, down from 11 in Q3 2019.
- Funds reported $0 of Health Sciences Acquisitions Corporation Warrants stock for Q4 2019, down 100% quarter-over-quarter.
- 0 funds opened new Health Sciences Acquisitions Corporation Warrants positions in Q4 2019 and 11 closed out, a net change of -11 holders.
- The largest Health Sciences Acquisitions Corporation Warrants seller in Q4 2019 was Boothbay Fund Management, an estimated $4.33M sold.
Based on aggregated 13F filings for Q4 2019.